“Protection against severe disease is already quite strong so an additional booster doesn’t add all that much protection,” says John Moore, an immunologist at Weill Cornell Medical College in New York. Others argue the focus should be on those at high risk because most people are still well protected against severe disease from previous vaccinations and infections. How many people will get the new vaccines? The best way to move on is just to get your COVID shot and know that’s going to provide a good amount of protection,” Jha says. “I understand that, you know, it’s been a long pandemic and people just want to move on. There are a lot of good reasons to get your annual COVID shot,” Jha says. “For younger, healthy people, I say: Look, getting the vaccine will reduce your risk of, you know, just being out of school, being out of work for a while. “I think it’s important for us to maintain our immunity because COVID is still around and as we’re seeing now it’s still capable of infecting a lot of people and hurting and killing some of them.” Robert Wachter of the University of California, San Francisco. I will encourage friends and family to get one,” says Dr. Some outside experts think everyone who’s eligible should get boosted, especially because the number of people catching the virus and getting so sick they’re ending up in the hospital and dying has been rising again for weeks. It’s unclear what the CDC will recommend for younger, otherwise healthy people, including children. The CDC is likely to recommend the shots for anyone who’s at high risk for serious complications from COVID, such as older people and those with weaker immune systems or other health problems. Recommendations for vaccine rollout are in the worksĪ panel of advisers to the Centers for Disease Control and Prevention meets Tuesday to make recommendations on the rollout of the vaccines. Moderna and Pfizer say they have produced ample supplies of their vaccines.
CDC VACCINE PASSPORT SERIES
The shots would be given as a single dose for most people 5 years of age and older, regardless of prior COVID-19 vaccination history.Ĭhildren younger than 5 may be eligible for multiple doses of this season’s vaccine if they had not previously finished a three-dose series with earlier COVID-19 vaccines. “So I’m actually quite optimistic this new vaccine is going to be protective.” Ashish Jha, the dean of the Brown School of Public Health who served as the White House COVID-19 Response Coordinator. “The data so far suggest that the new COVID vaccines should be really quite effective against even the new emerging variants that we have seen come up in the last weeks,” Dr. The vaccine makers and FDA say that the vaccine should still provide good protection against COVID. The vaccines target the omicron subvariant called XBB.1.5, which is no longer the most common strain in circulation. We very much encourage those who are eligible to consider getting vaccinated.” “The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness, and manufacturing quality. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, in a statement. “Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” said Dr. The vaccines from Moderna and Pfizer and its partner BioNTech were approved Monday for people 12 and older and under an emergency use authorization for children ages 6 months to 11 years old.
The Food and Drug Administration approved a new round of vaccines against COVID-19. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5.
Another round of COVID-19 vaccines is on the way.
0 kommentar(er)
